These documents pertain to the following article:

Kesselheim AS, Mello MM, Studdert DM.  Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints. PLoS Med 2011;8(4):e1000431. doi:10.1371/journal.pmed.1000431.

Warner Lambert

Complaint 1 (.pdf format)

Serono

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

InterMune

Complaint 1 (.pdf format)

Bristol Myers-Squibb

Complaint 1 (.pdf format)

Cell Therapeutics

Complaint 1 (.pdf format)

Orphan Medical

Complaint 1 (.pdf format)

Medicis

Complaint 1 (.pdf format)

Cephalon

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

Complaint 4 (.pdf format)

Eli Lilly

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

Complaint 4 (.pdf format)

Pfizer

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

Complaint 4 (.pdf format)

Complaint 5 (.pdf format)

Complaint 6 (.pdf format)

Complaint 7 (.pdf format)

Complaint 8 (.pdf format)

AstraZeneca

Complaint 1 (.pdf format)

Ortho-McNeil-Janssen

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Novartis Case 1

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

Complaint 4 (.pdf format)

Forest Labs

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Allergan

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Complaint 3 (.pdf format)

Novartis Case 2

Complaint 1 (.pdf format)

Scios

Complaint 1 (.pdf format)

Complaint 2 (.pdf format)

Wyeth

Complaint 1 (.pdf format)